Abstract
Background
Despite organ shortages, the discard rate of deceased donor kidneys is high. Risk factors for this trend warrant further study.
Methods
We investigated reasons for discard in a cohort of brain death donors with marginal kidneys and procurement biopsies. Paraffin embedded procurement biopsies were systematically reevaluated and graded for the purpose of the study. Assessment included percentage of global glomerulosclerosis, Banff Lesion scores and tubular epithelial damage. Donor-, transplant process-, perfusion quality-, histopathology-, and recipient-related parameters were compared between discarded and transplanted organs.
Results
Although most clinical characteristics were similar between donors whose kidneys were transplanted and those whose kidneys were procured but discarded, discarded kidneys were more likely to be from donors with hepatitis C, to have undergone wedge biopsies, to show changes of acute and chronic injury and to be deemed poor quality. Except for obvious anatomic abnormalities, kidneys were often discarded due to the findings of procurement biopsies. Donors of kidneys discarded for histologic reasons more often had hypertension, coronary artery disease, stroke, and increased serum creatinine. The reason for discard was unknown in 20% of cases. Discarded kidneys came from donors who appeared to be clinically similar to donors whose kidneys were utilized for transplant.
Conclusion
A considerable proportion of discarded kidneys were of acceptable quality. The analysis of the outcome of every recovered organ could help to overcome this problem. Procurement biopsies more often lead to discard than to transplantation of recovered organs. Proper handling during allocation has to be determined.
Graphical abstract
Similar content being viewed by others
Data availability
Data discussed in this study are available on request by the corresponding author.
Abbreviations
- ADQI:
-
Acute dialysis quality initiative
- AKI:
-
Acute kidney injury
- CMV:
-
Cytomegalovirus
- DBDs:
-
Diseased brain death donors
- DCDs:
-
Deceased cardiac death donors
- ECDs:
-
Extended criteria donors
- FSGS:
-
Focal segmental glomerulosclerosis
- ICU:
-
Intensive care unit
- IFTA:
-
Interstitial fibrosis and tubular atrophy
- NC:
-
Nephrocalcinosis
- TMA:
-
Thrombotic microangiopathy
References
Frei U, Noeldeke J, Machold-Fabrizii V et al (2008) Prospective age-matching in elderly kidney transplant recipients—a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 8:50–57
Merion RM, Ashby VB, Wolfe RA et al (2005) Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294:2726–2733
Wolfe RA, Ashby VB, Milford EL et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730
Lentine KL, Smith JM, Hart A et al (2022) OPTN/SRTR 2020 annual data report: kidney. Am J Transplant 22(Suppl 2):21–136
Chatzikyrkou C, Scurt FG, Clajus C et al (2019) Predictors of outcomes of living kidney donation: impact of sex, age and preexistent hypertension. Transplant Proc 51:396–404
Eckman MH, Woodle ES, Thakar CV et al (2020) Cost-effectiveness of using kidneys from HCV-viremic donors for transplantation into HCV-uninfected recipients. Am J Kidney Dis 75:857–867
Furian L, Nicolò A, Di Bella C et al (2020) Kidney exchange strategies: new aspects and applications with a focus on deceased donor-initiated chains. Transpl Int 33:1177–1184
Scurt FG, Ewert L, Mertens PR et al (2019) Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis. Lancet 393:2059–2072
Orandi BJ, Luo X, Massie AB et al (2016) Survival benefit with kidney transplants from HLA-incompatible live donors. N Engl J Med 374:940–950
Scurt FG, Mertens PR, Chatzikyrkou C (2019) Clinical outcomes after ABO-incompatible renal transplantation—authors’ reply. Lancet 394:1989–1990
Stewart DE, Garcia VC, Rosendale JD et al (2017) Diagnosing the decades-long rise in the deceased donor kidney discard rate in the United States. Transplantation 101:575–587
Yu K, King K, Husain SA et al (2020) Kidney nonprocurement in solid organ donors in the United States. Am J Transplant 20:3413–3425
Mohan S, Chiles MC, Patzer RE et al (2018) Factors leading to the discard of deceased donor kidneys in the United States. Kidney Int 94:187–198
Zaza G, Cucchiari D, Becker JU et al (2023) European Society for Organ Transplantation (ESOT)-TLJ 3.0 consensus on histopathological analysis of pre-implantation donor kidney biopsy: redefining the role in the process of graft assessment. Transpl Int 36:11410
Girolami I, Gambaro G, Ghimenton C et al (2020) Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys. J Nephrol 33:167–176
Dasari S, Chakraborty A, Truong L et al (2019) A systematic review of interpathologist agreement in histologic classification of lupus nephritis. Kidney Int Rep 4:1420–1425
Rao PS, Ojo A (2009) The alphabet soup of kidney transplantation: SCD, DCD, ECD–fundamentals for the practicing nephrologist. Clin J Am Soc Nephrol 4:1827–1831
Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212
Hamed MO, Chen Y, Pasea L et al (2015) Early graft loss after kidney transplantation: risk factors and consequences. Am J Transplant 15:1632–1643
Siedlecki A, Irish W, Brennan DC (2011) Delayed graft function in the kidney transplant. Am J Transplant 11:2279–2296
Sapir-Pichhadze R, Pintilie M, Tinckam KJ et al (2016) Survival analysis in the presence of competing risks: the example of waitlisted kidney transplant candidates. Am J Transplant 16:1958–1966
Mengel M, Sis B, Haas M et al (2012) Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 12:563–570
Liapis H, Gaut JP, Klein C et al (2017) Banff histopathological consensus criteria for preimplantation kidney biopsies. Am J Transplant 17:140–150
Gwinner W, Suppa S, Mengel M et al (2005) Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant 5:1934–1941
Schumann-Bischoff A, Schmitz J, Scheffner I et al (2018) Distinct morphological features of acute tubular injury in renal allografts correlate with clinical outcome. Am J Physiol Renal Physiol 315:F701-f710
Pieters TT, Falke LL, Nguyen TQ et al (2019) Histological characteristics of acute tubular injury during delayed graft function predict renal function after renal transplantation. Physiol Rep 7:e14000
Bajwa M, Cho YW, Pham PT et al (2007) Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation 84:1399–1405
Sung RS, Christensen LL, Leichtman AB et al (2008) Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant 8:783–792
Cheungpasitporn W, Thongprayoon C, Vaitla PK et al (2020) Degree of glomerulosclerosis in procurement kidney biopsies from marginal donor kidneys and their implications in predicting graft outcomes. J Clin Med 9:1469
Sood P, Randhawa PS, Mehta R et al (2015) Donor kidney microthrombi and outcomes of kidney transplant: a single-center experience. Clin Transplant 29:434–438
Li P, Gupta S, Mothi SS et al (2021) Histopathologic correlates of kidney function: insights from nephrectomy specimens. Am J Kidney Dis 77:336–345
Becker JU, Mayerich D, Padmanabhan M et al (2020) Artificial intelligence and machine learning in nephropathology. Kidney Int 98:65–75
Acknowledgements
We would thank the following German transplant centers for providing us with recipient data for the present analysis: Transplantationszentrum Uniklinik RWTH Aachen; Transplantation Berlin-Charité-Universität Berlin; Transplantationszentrum Bochum; Transplantationszentrum-Universitätsklinikum Bonn; Dr. Frans Zantvoort, Klinikum Bremen Mitte; Transplantationszentrum Uniklinik Düsseldorf; Transplantationszentrum-Uniklinikum Essen; Prof. Dr. med. Martina Koch, Universitätsklinikum Hamburg-Eppendorf; Transplantationschirurgie-Uniklinik Innsbruck; Transplantationszentrum-Uniklinik Köln; PD Dr. med. Antje Habicht, Transplantationszentrum München der LMU-LMU Klinikum; Prof. Dr. med. Bernhard Banas, Universitäres Transplantationszentrum Regensburg; PD Dr. med. Martin Nitschke, Universitätsklinikum Schleswig-Holstein; Dr. Peter Weithofer, Transplantationszentrum Süd-Niedersachsen.
Author information
Authors and Affiliations
Contributions
CC and FGS conceived the study; JUB re-evaluated the biopsies; CC acquired recipient data; CLFF provided donor data on behalf of the DSO; CC wrote the manuscript; FGS created the tables and figures and performed the statistical analysis. TW participated in the acquisition of donor and recipient data. AE and AS provided intellectual input, reviewed, and edited the manuscript. All authors approved the final version of the revised manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interests to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Scurt, F.G., Fischer-Fröhlich, CL., Wassermann, T. et al. Histological and clinical evaluation of discarded kidneys in a European cohort of deceased brain death donor kidneys of marginal quality. J Nephrol 36, 2587–2600 (2023). https://doi.org/10.1007/s40620-023-01785-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-023-01785-8